Please upgrade your browser.
Very few studies have followed patients with renal cell carcinoma for long enough to characterize late relapses. Newly published research suggests that late-recurring tumours are more likely to be of low nuclear grade and show a better response...
Evidence from a Meta-Analysis of Observational Studies
Christopher G. Wood, M.D., F.A.C.S., was honored at the 12th International Kidney Cancer Symposium, held in Chicago, for his career-long commitment to advancing kidney cancer research.
In two independent analyses comparing robotic-assisted surgery and open surgery performed on patients with urologic cancers, researchers found that robotic-assisted surgery results in fewer overall complications during and after surgery, less blood loss and shorter length of hospital stay.
Designed to Target Advanced Metastatic Renal Cell Carcinoma, the Study Will Determine the Maximum Tolerated Dose of Debio 0932 in Combination With Everolimus.
Reduced expression of a senescence-associated protein is associated with worse outcome in patients with renal cell carcinoma (RCC), study findings show.
Tumor grade and American Joint Committee on Cancer stage have emerged as the most important predictors of mortality in a competing risks analysis of patients undergoing nephrectomy for renal cell carcinoma (RCC).
To compare demographics, pathologic features, performance scores, comorbidities, symptoms and responses to quality of life (QoL) surveys between nephron-sparing surgery (NSS) and radical nephrectomy (RN) patients prior to surgical intervention.
President Obama gives his opinion concerning implementation of the Affordable Care Act, also known as "Obamacare."
It's difficult to find an accurate number, and the government isn't talking.
|Powered by NeonCRM|